268 results on '"Hurwitz, Herbert"'
Search Results
2. Phase I Study Evaluating Glesatinib (MGCD265), An Inhibitor of MET and AXL, in Patients with Non-small Cell Lung Cancer and Other Advanced Solid Tumors
3. Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database
4. Trajectories of body weight change and survival among patients with mCRC treated with systemic therapy: Pooled analysis from the ARCAD database
5. Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
6. Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
7. Purpose and Benefits of Early Phase Cancer Trials: What do Oncologists Say? What do Patients Hear?
8. The effects of lapatinib on cardiac repolarization: results from a placebo controlled, single sequence, crossover study in patients with advanced solid tumors
9. A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors
10. Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer
11. A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours
12. An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance)
13. A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer
14. A leave-one-out cross-validation SAS macro for the identification of markers associated with survival
15. Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors
16. The search for biomarkers to direct antiangiogenic treatment in epithelial ovarian cancer
17. A Phase Ib Study of Combined VEGFR and mTOR Inhibition With Vatalanib and Everolimus in Patients With Advanced Renal Cell Carcinoma
18. Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database.
19. Genetic variation determines VEGF-A plasma levels in cancer patients
20. Motesanib with or without panitumumab plus FOLFIRI or FOLFOX for the treatment of metastatic colorectal cancer
21. Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study
22. Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study
23. A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors
24. Development and utilization of a combined LC–UV and LC–MS/MS method for the simultaneous analysis of tegafur and 5-fluorouracil in human plasma to support a phase I clinical study of oral UFT®/leucovorin
25. An Intervention to Improve Cancer Patients' Understanding of Early-Phase Clinical Trials
26. Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
27. An open-label study to determine the maximum tolerated dose of the multitargeted tyrosine kinase inhibitor CEP-11981 in patients with advanced cancer
28. A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors
29. Effects of the combination of TRC105 and bevacizumab on endothelial cell biology
30. Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors
31. Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancer
32. Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer
33. Clinical Outcomes of Patients With Advanced Gastrointestinal Stromal Tumors: Safety and Efficacy in a Worldwide Treatment-Use Trial of Sunitinib
34. Multiagent Chemotherapy for Isolated Colorectal Liver Metastases: A Single-centered Retrospective Study
35. Phase I and pharmacokinetic study of pazopanib and lapatinib combination therapy in patients with advanced solid tumors
36. Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors
37. Partner-assisted emotional disclosure for patients with GI cancer: 8-week follow-up and processes associated with change
38. A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors
39. Carcinoma of the Ampulla of Vater: Patterns of Failure Following Resection and Benefit of Chemoradiotherapy
40. Lack of food effect on single-dose pharmacokinetics of brivanib, and safety and efficacy following multiple doses in subjects with advanced or metastatic solid tumors
41. Addition of Bevacizumab to Irinotecan- and Oxaliplatin-Based Preoperative Chemotherapy Regimens Does Not Increase Morbidity after Resection of Colorectal Liver Metastases
42. Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies
43. Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study†
44. The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
45. A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors
46. Significance of Histological Response to Preoperative Chemoradiotherapy for Pancreatic Cancer
47. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
48. Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study
49. Neoadjuvant Chemoradiation for Localized Adenocarcinoma of the Pancreas
50. Staging of pancreatic cancer before and after neoadjuvant chemoradiation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.